This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Chlorpromazine

Authoring team

Chlorpromazine is the main drug of the group of phenothiazines, and the prototype of all neuroleptics, having been introduced into psychiatry by Delay in 1952. It is a group 1 phenothiazine.

It has strong sedative, alpha-2 blocking and antiemetic actions and moderate extrapyramidal effects. It is the standard preparation for acutely excited patients.

Usual dose: Initial dose is 25mg tds or 75mg at night. The usual maintenance dose is 50-100mg tds. (up to 1000mg/day in special circumstances). Also used in smaller doses as an anxiolytic.

The summary of product characteristics should be consulted before prescribing this drug.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.